Ecog 전극 시장 보고서 : 동향, 예측 및 경쟁 분석(-2035년)

Ecog Electrode Market

The future of the global ecog electrode market looks promising with opportunities in the neurology, neurosurgery, neurorehabilitation, cognitive neuroscience, and biomedical engineering markets. The global ecog electrode market is expected to reach an estimated $2,488.1 million by 2035 from $590.3 million in 2027 with a CAGR of 19.8% from 2027 to 2035. The major drivers for this market are the increasing prevalence of neurological disorders, the rising demand for non-invasive brain monitoring, and the growing adoption of neurostimulation therapies.

• Lucintel forecasts that, within the form factor category, depth electrodes is expected to witness the highest growth over the forecast period due to more deep brain surgery cases.
• Within the application category, neurosurgery is expected to witness the highest growth over the forecast period due to more intricate and involved types of brain surgery.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period due to better infrastructure and more investments in neurological surgery.

Emerging Trends in Ecog Electrode Market

Between 2025 and 2027, demand for electrodes in clinical and research environments will cease to be exclusively for experimental neurosurgery. Lucintel believes there will be focus on higher channel counts, gentler interfaces, and quicker surgical deployment. The growth of academic brain-computer interface programs, institutional trials, and neurotechnology investments will begin to increase adoption, but limitations such as reimbursement, regulations, and the lack of evidence will encourage further innovation rather than expansive adoption.

• High-density Recording: An increasing number of research platforms in 2025 shifted toward the use of ECoG arrays with 128 and 256 contacts from the previous use of 64 contacts. This trend is expected to continue through 2030 with the goal of higher spatial resolution of both epilepsy surgery and brain-computer interfaces.
• Flexible Biomaterials: In 2025, 2027 prototypes used polyimide, silicone, and ultrathin polymer substrates, among other new materials, to more closely contact the cortex than previously used rigid arrays. Improving tissue-contact stability and reducing tissue disturbance is expected to increase the duration of chronic recording applications in the next 3 to 5 years.
• Minimally Invasive Delivery: In 2025, delivery of ECoG was focused in clinical practice on subdural and epidural augmentation. In 2026, translational work began to focus on shortening implantation time. The extent to which therapeutic implant use will move beyond large specialized research centers will be the result of reducing the burden of craniotomy.
• Wireless and Automated Systems: By 2027, implant work will begin to use wireless telemetry in tandem with automated real-time classification systems. Reducing the need for cables and increasing the speed and ease of interpretation will make intraoperative and remote workflows more feasible in the next few years.
• Personalized Neurostimulation: In 2025, combining ECoG sensing and closed-loop responsive stimulation began to shift the focus of therapy from standard neurostimulation to personalized methods. This convergence will increase the value of neurostimulation for epilepsy, movement disorders, and neuro prosthetics.

The ecog electrode market is now focused on incorporating discipline. Ease-of-use and modular arrays are preference for buyers. With respect to software, they are looking for systems that are both user-friendly and reliable. High density arrays will lead the research domain, while flexible and minimally invasive designs will be more important for the first clinical implementations. Manufacturers that can fill the gap of longitudinal data and consistency of manufacture will be the first to form collaborations as neurotechnology programs expand.

Recent Developments in the Ecog Electrode Market

The rush on ECoG electrode activity is slated to pick up speed through 2025-2027 as regulators, hospitals, and neurotechnology firms turn attention from research on recording toward implantation of therapeutic systems. Lucintel anticipates that market demand will correlate to epilepsy surgery, brain-computer interfaces (BCI) and cortical mapping, but continues to constrain market progress due to reimbursement, surgical challenges, and the larger issues of long-term biocompatibility.

• FDA Clears Cortical Interfaces: Precision Neuroscience's Layer 7 cortical interface secured FDA 510(k) clearance in May 2025 for temporary intraoperative brain-surface recording. This first approval within this space is likely to boost confidence in thin-film ECoG and shorten decision making across neurosurgical centers in the next 5 years.
• Neural Interface Investment: Neuralink announced in January 2026 that it had over 20 implants through its PRIME study, positioning them in the earliest stages of investment and recruitment for clinical work to move away from standalone diagnostic devices and electrodes and develop scalable, implantation systems with a higher focus on wireless and higher channel counts.
• Hospital Research Partnerships: Neuratech companies entered into agreements to run studies with academic medical centers in 2025 that focused on the clinical applications of high-density cortical arrays for speech restoration and motor control. These collaborations provide human data which allows companies to further refine their high-density cortical electrode arrays and also justify purchasing high-density cortical arrays by specialized hospitals.
• Higher-density Electrode Launches: 2025 saw new offerings for higher-density arrays surpassing 1,000 recording channels. Density at this level is expected to enable BCIs, but the rest of the technology, including heating, still determines the practical market for such devices.
• Government-backed Clinical Funding: Government funding for neurotechnology dominated both the NIH and the BRAIN Initiative, with numerous grants awarding $2-4 million per program for 2025. Public funding has the potential to offset the risk of early development and expand market access to not only epilepsy, but to paralysis rehabilitation and assisted communication.

While early market indication concentration exists within the clinic, strong signals for market dominance exist with the combination of clinically defensible, cost-effective, and safe technology. Within the 2025-2027 timeframe, the number of available federal market approvals, along with hospital trials, will outweigh the number of available prototype electrode channels. The reimbursement framework will determine whether the growth of ECoG electrodes expands beyond specialty clinics.

Strategic Growth Opportunities in the Ecog Electrode Market

From 2024 to 2026, commercial interest in the ecog electrode market will likely increase as brain-computer interface research shifts towards clinical implementation. Lucintel anticipates that hospital neurology, neuroprosthetics and investigational stimulation will be the most important customer segments. Improving manufacturing techniques, shortening procedures and increasing investment in neural data platforms are expanding the customer base beyond specialist research laboratories.

• Neuroprosthetic Interfaces: High-density ECoG arrays can facilitate the decoding of motor signals for control of robotics and assistive communication devices. Precision Neuroscience's 1,024- channel Layer 7-T received FDA 510(k) clearance in June 2025. Increased channel density will warrant charging a premium over the next 3 to 5 years and facilitating clinical partnerships.
• Expanded Epilepsy Surgery: With longer duration implantable devices, hospitals have greater interest in alternatives to surgical implantation. A review published in 2025 indicated that ECoG and stereo-EEG are integral components of thousands of epilepsy assessments performed worldwide. This segment of the market is poised for significant growth as surgical centers standardize single-use electrodes and integrate them into surgical planning software.
• Conformable Electrodes: Thin film technologies can decrease tissue trauma and increase the duration of cortical recordings. In February 2025, a study published in a peer-reviewed journal presented a 64-channel flexible ECoG array. This segment is poised to grow as neurosurgeons prefer to use low-profile devices for complex cases and repeat surgery.
• Expanding East: Neurosurgical procedures and clinical neurotechnology research are increasing in Japan, South Korea, China and India. In 2024, the China National Medical Products Administration (NMPA) approved over 4,000 medical devices, offering greater opportunities for hospitals to adopt advanced technologies in 2025. This segment will further grow as domestic manufacturing and regulations are improved.
• Customized Solutions: Suppliers of electrode arrays can integrate planning software, signal analytics, and other designs specific to particular procedures. One clinical BCI program reported decoding performance above 90% in selected communication tasks in October 2025. bundled solutions will lead to competition for recurring software, support, and engineering services. rather than for hardware.

The strongest suppliers will integrate reliable implantation with high channel counts and usable data flows. Hospitals want evidence and predictable procurement along with service support rather than experimental hardware. The next five years should define the commercial reach and partnerships with neurosurgeons, BCI developers, and contract manufacturers. Regulatory and reimbursement frameworks will remain critical for products moving from research to more routine clinical application.

Ecog Electrode Market Drivers and Challenges

Electrocorticography (ECoG) electrode market growth is attributed to increasing cases of neurologic disorders, technological advancements, clinical demand, and evolving regulations. Because of technological advancements, the use of ECoG electrodes and other brain computer interfaces has expanded. Advances in materials science along with the use of advanced manufacturing techniques have also improved signal to noise ratios. Barriers to market entry for ECoG electrodes include long and cost intensive approvals, custom manufacturing, and barriers to market entry. Innovation along with hospital and personalized neurocare investments have the potential to drive the market over the next five to seven years. Clinical effectiveness, safety of patients, and the balance between cost and production are expected to define the scope of the ECoG electrodes market in the coming years.

The factors responsible for driving this market include:-

• Clinical Demand: Increasing usage of intracranial monitoring for the epilepsy that does not respond to medications is supporting the demand for ECoG electrodes. Better presurgical localization will enable the clinician to identify the region of the seizure and help avoid unnecessary tissue removal. Epilepsy has affected over 50 million people worldwide by 2025. During this period, a greater number of people will seek specialized epilepsy centers for treatment because more individualized neurosurgical plans will be offered. The electrodes will be requested with greater frequency as hospitals seek more precise brain activity monitoring methods in comparison to scalp electroencephalography and other less invasive techniques.
• Technology Improvements: Improved contact density and flexibility, wireless systems, and advanced insulation show promise in improving quality and ease-of-use in recording and surgical applications. Modern electrodes can now capture localized recordings with low artifacts and ease of placement. In the last five years, multiple research systems have started evaluating arrays with hundreds of recording contacts. In the next three to five years, the use of these technologies in epilepsy, motor decoding, speech, and Brain Computer Interface (BCI) research will grow. Better integration of software and artificial intelligence will help interpret data with more certainty and reduce the time it takes to provide clinical feedback.
• Brain-Computer Interface Expansion: With the recent rise in brain-computer interface investment, the demand for high-resolution cortical recording technology has also increased. Electrocorticography (ECoG) captures stronger and more localized signals than many noninvasive recording techniques while being less invasive than penetrating electrodes. In 2025, several clinical and research programs studied the use of neural interfaces to assist communication and control of assistive devices and rehabilitation therapy. Some systems were comprised of more than 100 recording channels. In the next three to five years, research on neural decoding and rehabilitation will create applications of ECoG beyond the traditional use of epilepsy monitoring. The improvement of long-term safety will be instrumental in the diversification of revenue from these technologies.
• Product Innovation: In order to improve upon current options, manufacturers are working on creating designs for electrodes that are flexible, conformable, and application specific. In order to decrease surgical complication risks, these designs aim to provide more cortex coverage. Examples of these designs include subdural grids, strips, and depth electrodes as well as high-density arrays. To meet the requests of potential users, product development over the next five years is expected to focus on more bio-compatible, less intrusive materials. Over the next 3 to 5 years, innovative designs will assist in wider product adoption, especially in clinical and research fields. Innovation in electrodes will be especially beneficial to surgeons looking for custom geometries and more reliable fixations, as well as integration of advanced neurotechnology.
• Healthcare Infrastructure Investment: Neurosurgery, epilepsy program, and neurotechnology research center expansions create a larger market available to potential users. ECoG procedures are adopted more often by hospitals investing in specialized surgery rooms and advanced monitoring systems. In 2025 many healthcare systems in various geographical areas continues to grow investment in neurological diagnostic systems and surgical services, although the extent of funding varied. Within the next 3 to 5 years, infrastructure growth is expected to encourage market growth in developing countries. The extent of market growth will be dependent upon funding, training, and partnerships between hospitals and device manufacturers.

The challenges facing this market include:

• Cost of Procedures: ECoG procedures are expensive due to the cost of specialized electrodes, requirements of the operating room, the need for neurosurgeons, and the fact that they require extended monitoring. Relative to non-invasive tests, ECoG procedures are expensive. Restricted reimbursement and limited hospital budgets will deter adoption. Taking a contextual approach, in 2025, the healthcare industry adopted a preference for more cost-effective diagnostic pathways in comparison to invasive monitoring. It is likely that this preference will continue over the next three to five years and will have a significant effect on adoption, especially in developing countries. Clinical evidence with improved outcomes, reduced disposable costs, and improved efficient workflows will encourage more favorable reimbursement and hospital purchasing.
• Regulatory and Safety Concerns: Manufacturers must meet requirements for biocompatibility, sterility, durability, and performance of ECoG electrodes which can take a long time. Regulatory approval can be a costly and time-consuming process. Developments for ECoG systems in 2025 were focused on creating neurological devices for long-term implantation and in the field of brain-computer interface. It is expected that for the next three to five years, safety concerns and post-market surveillance will be of most concern. Innovation in the field will take time due to the lengthy clinical trails and compliance costs and will primarily occur at larger companies.
• Shortage of Expert Skill: Optimal use of ECoG requires a multi-disciplinary team of neurosurgeons, engineering and data specialists, neurophysiologists. Existing shortages could impact the volume and interpretation of ECoG studies, discourage hospitals from purchasing advanced systems. In 2025, regional variation and gaps in access to specialized Neurotech teams was particularly troubling beyond major academic centers. The next three to five years will likely see workforce challenges slow the market. The existing gap will likely be filled by investment in the training and first-line support of remote equipment along with the introduction of more automated analysis tools.

Considering that the markets for Epilepsy care, BCI, and neuroscience will grow in parallel with precision Neurosurgery, there is a growing, predictable demand for ECoG. Signal acquisition technology has progressed to the point of quality, flexible, and extensible systems, and coupled with improvements in infrastructure and funding of innovative products, science is poised to adopt ECoG. Market growth is expected to be hampered by long and complex regulations, high costs, and insufficient numbers of trained personnel. Successful firms will address the needs of the market best by incorporating more evidence-based designs and intelligent manufacture with improved safety and training support. The conversion of promising Neurotechnology to affordable products of sufficient safety, usability, and dependability will drive the market.

List of Ecog Electrode Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies ecog electrode market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the ecog electrode market companies profiled in this report include-

• NeuroNexus Technologies
• G.Tec Medical Engineering GmbH
• Blackrock Neurotech
• NeuroOne Medical Technologies Corporation
• MicroProbes For Life Science
• Ripple Neuro
• Ad-Tech Medical Instrument Corporation
• PMT Corporation
• Integra LifeSciences Holdings Corporation
• CorTec GmbH

Ecog Electrode Market by Segment

The study includes a forecast for the global ecog electrode market by form factor, placement, material, application, and region.

Ecog Electrode Market by Form Factor [Value ($M) from 2019 to 2035]:

• Grid Electrodes
• Strip Electrodes
• Depth Electrodes

Ecog Electrode Market by Placement [Value ($M) from 2019 to 2035]:

• Subdural Electrodes
• Epidural Electrodes

Ecog Electrode Market by Material [Value ($M) from 2019 to 2035]:

• Metal-based Electrodes
• Polymer-based / Flexible Electrodes
• High-Density / Micro-ECoG Electrodes

Ecog Electrode Market by Application [Value ($M) from 2019 to 2035]:

• Neurology
• Neurosurgery
• Neurorehabilitation
• Cognitive Neuroscience
• Biomedical Engineering
• Others

Ecog Electrode Market by Region [Value ($M) from 2019 to 2035]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Ecog Electrode Market

The ecog electrode market is shifting away from neurosurgery research and toward clinical and research market regulation. The US began issuing regulatory clearances in 2025, Eurozone financing of neurotechnology began to rise, and neuroengineering continued to develop in China, India, and Japan. In its recent market report, Lucintel concluded that commercialization was linked to clinical verification and reimbursement.

• United States: Precision Neuroscience received FDA 510(k) clearance for its Layer 7 cortical electrode in June 2025. The system includes 1,024 recording contacts and is a high density cortical recording system. The system's clearance should drive hospital adoption, evidence generation, and infrastructure in the next three to five years.
• China: More than 250 innovative medical devices received approval in 2025 from the National Medical Products Administration (NMPA) of China. Chinese hospitals supported invasive brain-computer-interface trials. Development of Chinese approved domestic neuro technologies is important because it lessens the reliance on imported technologies and potentially generates more comprehensive clinical data.
• Germany: CorTec, based in Freiburg, Germany, and its partner Blackrock neurotech, continued development of their BCI platform, and integrated CorTec's wireless implant technology into recording and stimulation. The partnership is important because Germany's engineering infrastructure, in combination with a high level of clinical compliance in Europe, supports production and marketing of BCI systems in the next three to five years.
• India: The National Brain Research Centre and other leading institutions, funded by the Government of India, continued work on neural recording and brain-computer interfaces in 2025. This included research on epilepsy mapping led by hospitals with the assistance of subdural electrodes. Significance: Infrastructure for public-funded research in India can lead to growth in domestic validations; a workforce of technicians; and eventual purchases of supported systems.
• Japan: The Ministry of Health, Labour and Welfare in Japan continued to support advanced medical device R&D and regenerative medicine, while other institutions, including Osaka University, helped to advance human neurotechnology and cortical signal acquisition. Significance: The regulated Japanese clinical ecosystem and the country's world-class precision manufacturing can enable the conversion of laboratory ECoG systems to approved medical devices within 3-5 year

Features of the Global Ecog Electrode Market

• Market Size Estimates: ecog electrode market size estimation in terms of value ($M).
• Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
• Segmentation Analysis: ecog electrode market size by various segments, such as by form factor, placement, material, application, and region in terms of value ($M).
• Regional Analysis: ecog electrode market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different form factors, placement, materials, applications, and regions for the ecog electrode market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the ecog electrode market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the ecog electrode market by form factor (grid electrodes, strip electrodes, and depth electrodes), placement (subdural electrodes and epidural electrodes), material (metal-based electrodes, polymer-based / flexible electrodes, and high-density / micro-ecog electrodes), application (neurology, neurosurgery, neurorehabilitation, cognitive neuroscience, biomedical engineering, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 7 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global ECoG Electrode Market by Form Factor

• 4.1 Overview
• 4.2 Attractiveness Analysis by Form Factor
• 4.3 Grid Electrodes : Trends and Forecast 2019 to 2035
• 4.4 Strip Electrodes : Trends and Forecast 2019 to 2035
• 4.5 Depth Electrodes : Trends and Forecast 2019 to 2035

5. Global ECoG Electrode Market by Placement

• 5.1 Overview
• 5.2 Attractiveness Analysis by Placement
• 5.3 Subdural Electrodes : Trends and Forecast 2019 to 2035
• 5.4 Epidural Electrodes : Trends and Forecast 2019 to 2035

6. Global ECoG Electrode Market by Material

• 6.1 Overview
• 6.2 Attractiveness Analysis by Material
• 6.3 Metal-based Electrodes : Trends and Forecast 2019 to 2035
• 6.4 Polymer-based / Flexible Electrodes : Trends and Forecast 2019 to 2035
• 6.5 High-Density / Micro-ECoG Electrodes : Trends and Forecast 2019 to 2035

7. Global ECoG Electrode Market by Application

• 7.1 Overview
• 7.2 Attractiveness Analysis by Application
• 7.3 Neurology : Trends and Forecast 2019 to 2035
• 7.4 Neurosurgery : Trends and Forecast 2019 to 2035
• 7.5 Neurorehabilitation : Trends and Forecast 2019 to 2035
• 7.6 Cognitive Neuroscience : Trends and Forecast 2019 to 2035
• 7.7 Biomedical Engineering : Trends and Forecast 2019 to 2035
• 7.8 Others : Trends and Forecast 2019 to 2035

8. Regional Analysis

• 8.1 Overview
• 8.2 Global ECoG Electrode Market by Region

9. North American ECoG Electrode Market

• 9.1 Overview
• 9.2 North American ECoG Electrode Market by Form Factor
• 9.3 North American ECoG Electrode Market by Application
• 9.4 The United States ECoG Electrode Market
• 9.5 Canadian ECoG Electrode Market
• 9.6 Mexican ECoG Electrode Market

10. European ECoG Electrode Market

• 10.1 Overview
• 10.2 European ECoG Electrode Market by Form Factor
• 10.3 European ECoG Electrode Market by Application
• 10.4 German ECoG Electrode Market
• 10.5 French ECoG Electrode Market
• 10.6 Italian ECoG Electrode Market
• 10.7 Spanish ECoG Electrode Market
• 10.8 The United Kingdom ECoG Electrode Market

11. APAC ECoG Electrode Market

• 11.1 Overview
• 11.2 APAC ECoG Electrode Market by Form Factor
• 11.3 APAC ECoG Electrode Market by Application
• 11.4 Chinese ECoG Electrode Market
• 11.5 Indian ECoG Electrode Market
• 11.6 Japanese ECoG Electrode Market
• 11.7 South Korean ECoG Electrode Market
• 11.8 Indonesian ECoG Electrode Market

12. ROW ECoG Electrode Market

• 12.1 Overview
• 12.2 ROW ECoG Electrode Market by Form Factor
• 12.3 ROW ECoG Electrode Market by Application
• 12.4 Middle Eastern ECoG Electrode Market
• 12.5 South American ECoG Electrode Market
• 12.6 African ECoG Electrode Market

13. Competitor Analysis

• 13.1 Product Portfolio Analysis
• 13.2 Operational Integration
• 13.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 13.4 Market Share Analysis

14. Opportunities & Strategic Analysis

• 14.1 Value Chain Analysis
• 14.2 Growth Opportunity Analysis
  • 14.2.1 Growth Opportunity by Form Factor
  • 14.2.2 Growth Opportunity by Placement
  • 14.2.3 Growth Opportunity by Material
  • 14.2.4 Growth Opportunity by Application
• 14.3 Emerging Trends in the Global ECoG Electrode Market
• 14.4 Strategic Analysis
  • 14.4.1 New Product Development
  • 14.4.2 Certification and Licensing
  • 14.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

15. Company Profiles of the Leading Players Across the Value Chain

• 15.1 Competitive Analysis Overview
• 15.2 NeuroNexus Technologies
  • Company Overview
  • ECoG Electrode Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 15.3 G.Tec Medical Engineering GmbH
  • Company Overview
  • ECoG Electrode Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 15.4 Blackrock Neurotech
  • Company Overview
  • ECoG Electrode Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 15.5 NeuroOne Medical Technologies Corporation
  • Company Overview
  • ECoG Electrode Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 15.6 MicroProbes For Life Science
  • Company Overview
  • ECoG Electrode Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 15.7 Ripple Neuro
  • Company Overview
  • ECoG Electrode Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 15.8 Ad-Tech Medical Instrument Corporation
  • Company Overview
  • ECoG Electrode Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 15.9 PMT Corporation
  • Company Overview
  • ECoG Electrode Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 15.10 Integra LifeSciences Holdings Corporation
  • Company Overview
  • ECoG Electrode Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 15.11 CorTec GmbH
  • Company Overview
  • ECoG Electrode Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

16. Appendix

• 16.1 List of Figures
• 16.2 List of Tables
• 16.3 Research Methodology
• 16.4 Disclaimer
• 16.5 Copyright
• 16.6 Abbreviations and Technical Units
• 16.7 About Us
• 16.8 Contact Us